27-Hydroxycholesterol: a potential treatment for non-alcoholic steatohepatitis in mice
Sofie M. A. Walenbergh(Maastricht University Medical Centre), Ronit Shiri‐Sverdlov(Maastricht University), Eran Leitersdorf(Hebrew University of Jerusalem), Marion J. Gijbels(Maastricht University Medical Centre), Yasmin Dias Guichot(Maastricht University), D. Luetjohann(University of Bonn), Patrick J. van Gorp(Maastricht University), Veerle Bieghs(Universitätsklinikum Aachen), Ad Masclee(Maastricht University), Tim Hendrikx(Medical University of Vienna), Ger H. Koek(Maastricht University Medical Centre)
Data Archiving and Networked Services (DANS)
October 1, 2012
Cited by 1
Related Papers
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
|Cells|2020|538
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†
|Hepatology|2008|467
Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates
|Journal of Hepatology|2005|241